MPD: Project measures / variables set: Boon1 survival

Project measures / variables set: Boon1 survival

ID, description, units	MPD:46921 survival survival (days to death, max 30) [d] influenza A (H5N1) virus study
Measures	• dosage group: • low • medium • high
Data set, strains	Boon1 inbred 23 strains sex: f age: 6-9wks
Procedure	health assessment
Comparison	multiple dosage cohorts but no control group
Ontology mappings	VT:0010439 response to viral infection trait MP:0010769 abnormal survival MP:0020185 altered susceptibility to viral infection

Values Means Δ Means Z-scores

Graph Type Points Bars

Dimensions Width: × Height: px

Plot Options Hide Error Bars Strains on X-axis

Data Type:

Dimensions Height: px

Toggle Series

Plot Options Show Standard Error Show Point Labels Flip Axes Shared Tooltip Connect Gaps

Boon1 - survival (days to death, max 30)

ANOVA, Q-Q NORMALITY ASSESSMENT

ANOVA Summary

Factor	DF	Sum of squares	Mean sum of squares	F value	p-value (Pr>F)
dose	2	14665.2348	7332.6174	150.3955	< 0.0001
dose:strain	30	5210.9219	173.6974	3.5626	< 0.0001
Residuals	710	34616.4559	48.7556
strain	15	28433.609	1895.5739	38.8791	< 0.0001

Q-Q normality assessment based on residuals

INDIVIDUAL MEASURES

Project	ID		Treatment	Measure / Variable Description	Panel	Strains tested	Sex	Age
Boon1	46921	health assessment	influenza A (H5N1) virus	survival (days to death, max 30) [d] dose group: low survival_lo	inbred	18	f	6-9wks
Boon1	46922	health assessment	influenza A (H5N1) virus	survival (days to death, max 30) [d] dose group: medium survival_med	inbred	22	f	6-9wks
Boon1	46923	health assessment	influenza A (H5N1) virus	survival (days to death, max 30) [d] dose group: high survival_hi	inbred	21	f	6-9wks